Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB11 | O95342 | 1/20 | 1.00 |
| ▸ | AKR1C3 | P42330 | 6/20 | 0.58 |
| ▸ | AKR1C2 | P52895 | 6/20 | 0.58 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | CDC42 | P60953 | 1/20 | 0.58 |
| ▸ | RAC1 | P63000 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Naproxol SCHEMBL10395753 | 1.00 | ABCB11 (1.00) | ABCB11AKR1C3AKR1C2PTGS2PTGS1 | |
| Naproxol SCHEMBL30599771 | 1.00 | ABCB11 (1.00) | ABCB11AKR1C3AKR1C2PTGS2PTGS1 | |
| Naproxol SCHEMBL8471214 | 1.00 | ABCB11 (1.00) | ABCB11AKR1C3AKR1C2PTGS2PTGS1 | |
| Naproxol SCHEMBL29979997 | 1.00 | ABCB11 (1.00) | ABCB11AKR1C3AKR1C2PTGS2PTGS1 | |
| SCHEMBL11015086 | 0.97 | ABCB11 (0.93) | ABCB11AKR1C3AKR1C2PTGS2PTGS1 | |
| Naproxol SCHEMBL9451481 | 0.91 | ABCB11 (0.82) | ABCB11AKR1C3AKR1C2PTGS2PTGS1 | |
| SCHEMBL9009741 | 0.84 | ABCB11 (0.72) | ABCB11AKR1C3AKR1C2PTGS2PTGS1 | |
| SCHEMBL28346869 | 0.84 | ABCB11 (0.72) | ABCB11AKR1C3AKR1C2PTGS2PTGS1 | |
| SCHEMBL14783039 | 0.83 | ABCB11 (0.71) | ABCB11AKR1C3AKR1C2PTGS2PTGS1 | |
| SCHEMBL11806102 | 0.83 | ABCB11 (0.71) | ABCB11AKR1C3AKR1C2PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3669 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240307283-A1 | COMPOSITIONS AND METHODS FOR DECREASING PIGMENTATION | THE GENERAL HOSPITAL CORPORATION | 2024-09-19 | — | — | US | claimed |
| US-20240200072-A1 | Allogeneic Cartilage Regeneration | Tarachon, LLC (US) | 2024-06-20 | — | — | US | claimed |
| EP-4366837-A2 | COMPOSITSONS AND METHODS FOR DECREASING PIGMENTATION | The General Hospital Corporation (US) | 2024-05-15 | — | — | EP | claimed |
| EP-4335413-A2 | PROSTHETIC TISSUE VALVES | Cormatrix Cardiovascular, Inc. (US) | 2024-03-13 | — | — | EP | claimed |
| WO-2023212179-A2 | THERAPEUTIC COMPOSITIONS FOR SKIN DISORDERS AND WOUND REPAIR | UNIVERSITY OF MIAMI (US) | 2023-11-02 | — | — | WO | claimed |
| WO-2023283554-A2 | COMPOSITSONS AND METHODS FOR DECREASING PIGMENTATION | THE GENERAL HOSPITAL CORPORATION (US) | 2023-01-12 | — | — | WO | claimed |
| CN-115515680-A | Compositions and methods for assessing efficacy of neurotransmitter transporter inhibitors | 索元生物医药有限公司 | 2022-12-23 | — | — | CN | claimed |
| CN-115397515-A | Human anti-CD 33 antibodies and uses thereof | 弗莱德哈钦森癌症中心 | 2022-11-25 | — | — | CN | claimed |
| US-20220110979-A1 | FIBROBLAST REGENERATIVE CELLS | FIGENE, LLC | 2022-04-14 | — | — | US | claimed |
| EP-3908297-A1 | FIBROBLAST REGENERATIVE CELLS | Figene, LLC (US) | 2021-11-17 | — | — | EP | claimed |
| WO-2001015744-A1 | SYSTEMIC INFLAMMATORY MARKERS AS DIAGNOSTIC TOOLS IN THE PREVENTION OF ATHEROSCLEROTIC DISEASES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2001-03-08 | — | — | WO | claimed |
| CN-1284863-A | Topical compositions for NSAI drug delivery | NEXMED HOLDINGS INC (US) | 2001-02-21 | — | — | CN | claimed |
| EP-1003501-A4 | MEANS OF ASCERTAINING AN INDIVIDUAL'S RISK PROFILE FOR ATHEROSCLEROTIC DISEASE | BRIGHAM & WOMENS HOSPITAL (US) | 2001-01-17 | — | — | EP | claimed |
| EP-1028710-A1 | TOPICAL COMPOSITIONS FOR NSAI DRUG DELIVERY | Nexmed Holdings, Inc. (US) | 2000-08-23 | — | — | EP | claimed |
| US-6083996-A | COMPRISES ONE OR MORE NON-STEROID ANTIINFLAMMATORY AGENT, A NON-BASIC POLYMERIC SKIN PENETRATION ENHANCER AND A LIPOPHILIC SOLVENT CONTAINING ALIPHATIC ALCOHOL AND ALIPHATIC ESTER MIXTURE | NEXMED HOLDINGS, INC. (US) | 2000-07-04 | — | — | US | claimed |
| EP-1003501-A1 | MEANS OF ASCERTAINING AN INDIVIDUAL'S RISK PROFILE FOR ATHEROSCLEROTIC DISEASE | BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2000-05-31 | — | — | EP | claimed |
| WO-1999022716-A1 | TOPICAL COMPOSITIONS FOR NSAI DRUG DELIVERY | NEXMED HOLDINGS, INC. (US) | 1999-05-14 | — | — | WO | claimed |
| WO-1998043630-A1 | MEANS OF ASCERTAINING AN INDIVIDUAL'S RISK PROFILE FOR ATHEROSCLEROTIC DISEASE | BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 1998-10-08 | — | — | WO | claimed |
| EP-0466650-A2 | Improvements in non-steroidal anti-inflammatory therapy | WARNER-LAMBERT COMPANY (US) | 1992-01-15 | — | — | EP | claimed |
| US-4762851-A | ANTIINFLAMMATORY AGENTS | MERCK & CO., INC. (US) | 1988-08-09 | — | — | US | claimed |